Public Hospital Dist No 1 Skagit

Public Hospital Dist No 1 Skagit was paid $88.65M by Medicaid between Jan 2018 and Dec 2024, across 633 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 45% of everything it billed.

33Billing provider infoPUBLIC HOSPITAL DIST NO 1 SKAGIT
MOUNT VERNON, WA 98274

33aNPI1053357244assigned 06/22/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$88.65M

24GClaims2,607,790

24DCodes billed633

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#4 of 49

Median peer was paid$20.06M

This provider vs. median4.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	337,028	$12.44M
2019	355,556	$12.59M
2020	318,718	$10.64M
2021	398,005	$13.04M
2022	428,481	$13.98M
2023	427,288	$14.05M
2024incomplete	342,714	$11.91M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	45%	452,469	364,073	$39.90M
96361	Intravenous infusion, hydration; each additional hour	4.4%	15,024	12,179	$3.92M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.6%	24,890	23,279	$3.19M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.2%	23,870	22,176	$2.87M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.9%	24,452	21,908	$2.60M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	2.0%	26,795	25,448	$1.78M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.0%	8,058	7,669	$1.77M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.3%	3,695	3,523	$1.13M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.2%	5,739	3,103	$1.10M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.2%	9,146	8,749	$1.08M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	12,241	8,366	$1.05M
70450	Computed tomography, head or brain; without contrast material	1.0%	6,666	6,140	$889K

621 more codes

J0585	Injection, onabotulinumtoxina, 1 unit	1.0%	4,361	$887K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	4,091	$830K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,284	$828K
80053	Comprehensive metabolic panel	<1%	101,520	$722K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	5,771	$715K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	4,844	$682K
17110		<1%	3,545	$589K
G0378	Hospital observation service, per hour	<1%	12,035	$581K
20610		<1%	4,721	$542K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,595	$492K
59025	Fetal non-stress test	<1%	3,445	$483K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,812	$479K
64615		<1%	2,443	$461K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	6,096	$450K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,966	$393K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,981	$375K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	16,026	$372K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,786	$339K
36415	Collection of venous blood by venipuncture	<1%	169,173	$333K
96415		<1%	1,589	$302K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,809	$296K
76830	Ultrasound, transvaginal	<1%	3,305	$288K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	591	$282K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	11,833	$279K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	961	$277K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	99,918	$268K
11102		<1%	1,106	$256K
71046	Radiologic examination, chest; 2 views	<1%	14,426	$252K
84443	Thyroid stimulating hormone (TSH)	<1%	32,636	$247K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,185	$228K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	13,999	$226K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,802	$225K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	3,955	$223K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	731	$223K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,188	$215K
12001		<1%	1,048	$208K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	8,218	$184K
73630		<1%	9,320	$179K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	9,452	$176K
73221		<1%	933	$173K
93017		<1%	2,102	$173K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,196	$173K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	11,236	$173K
76801		<1%	2,683	$172K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,035	$168K
93971		<1%	1,938	$166K
11750		<1%	479	$166K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,510	$165K
52000		<1%	369	$161K
10060		<1%	942	$161K
J9271	Injection, pembrolizumab, 1 mg	<1%	32	$158K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	3,261	$158K
80061	Lipid panel	<1%	22,221	$151K
96375	Therapeutic injection; each additional sequential IV push	<1%	20,663	$151K
73562		<1%	7,207	$140K
73110		<1%	6,258	$140K
73130		<1%	6,564	$139K
73610		<1%	7,117	$138K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	17,871	$138K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	30,245	$136K
73030		<1%	6,628	$133K
72141		<1%	766	$125K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	21,138	$123K
84484		<1%	17,044	$121K
29125		<1%	720	$118K
90461		<1%	8,232	$114K
83036	Hemoglobin; glycosylated (A1C)	<1%	23,664	$111K
76770		<1%	1,173	$111K
87507		<1%	1,709	$110K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,689	$109K
17000		<1%	1,205	$107K
70496		<1%	647	$106K
84439		<1%	12,816	$106K
71250		<1%	1,369	$105K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,946	$101K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	11,230	$99K
90715		<1%	6,376	$92K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	17,665	$91K
71045	Radiologic examination, chest; single view	<1%	14,417	$91K
80048	Basic metabolic panel (calcium, ionized)	<1%	16,302	$90K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	13,691	$90K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,754	$89K
64450		<1%	432	$85K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	4,706	$85K
97597		<1%	2,804	$83K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,585	$83K
72100		<1%	3,530	$78K
96900		<1%	2,751	$78K
95886		<1%	731	$76K
69210		<1%	1,703	$76K
87086	Culture, bacterial; quantitative colony count, urine	<1%	22,353	$75K
85027		<1%	22,047	$75K
96367		<1%	2,311	$74K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,993	$73K
11100		<1%	265	$71K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,246	$71K
73140		<1%	3,867	$71K
96376		<1%	8,794	$70K
87040		<1%	6,850	$69K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	217	$69K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	1,954	$69K
10061		<1%	318	$67K
93975		<1%	997	$65K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	37	$64K
83605		<1%	7,503	$61K
82728		<1%	9,627	$60K
90651		<1%	3,470	$59K
97162		<1%	1,823	$58K
11055		<1%	490	$57K
73080		<1%	2,857	$57K
73560		<1%	3,429	$55K
11721		<1%	4,261	$55K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,258	$55K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	3,998	$54K
90686		<1%	12,297	$54K
11900		<1%	343	$54K
72040		<1%	2,351	$51K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	3,848	$51K
74018		<1%	3,006	$50K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	4,102	$50K
73502		<1%	2,827	$48K
76870		<1%	454	$46K
83690		<1%	18,303	$46K
95811		<1%	100	$45K
11056		<1%	491	$45K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,344	$45K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	3,086	$44K
98928		<1%	1,760	$43K
J7030	Infusion, normal saline solution , 1000 cc	<1%	35,665	$41K
83880		<1%	3,972	$40K
97161		<1%	1,109	$39K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,899	$39K
76536		<1%	411	$37K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,041	$36K
11104		<1%	119	$36K
90677		<1%	1,561	$35K
70498		<1%	673	$35K
82607		<1%	4,986	$35K
98927		<1%	1,820	$35K
83735		<1%	18,791	$35K
86140		<1%	11,115	$33K
95115		<1%	1,760	$33K
87077		<1%	10,987	$32K
12011		<1%	161	$32K
97803		<1%	759	$32K
90670		<1%	4,020	$31K
84702		<1%	5,125	$31K
84145		<1%	2,778	$31K
72110		<1%	1,366	$31K
83655		<1%	2,073	$31K
20550		<1%	254	$31K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,027	$30K
81001		<1%	19,218	$30K
83550		<1%	7,817	$29K
86592		<1%	5,733	$29K
83970		<1%	1,620	$29K
87070		<1%	5,883	$28K
73090		<1%	1,470	$28K
85379		<1%	4,034	$28K
99214	Doctor's office visit, returning patient (more involved)	<1%	448	$28K
81025		<1%	23,886	$28K
73590		<1%	1,508	$27K
86480		<1%	1,712	$26K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	5,906	$26K
83540		<1%	7,955	$26K
70486		<1%	367	$26K
97602		<1%	290	$25K
70491		<1%	164	$25K
94060		<1%	578	$25K
87181		<1%	10,069	$25K
98926		<1%	1,552	$25K
82075		<1%	5,849	$25K
95806		<1%	66	$25K
82570		<1%	6,698	$24K
0071A		<1%	635	$24K
J2704	Injection, propofol, 10 mg	<1%	16,369	$24K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	27	$24K
85610		<1%	13,363	$24K
80305		<1%	8,850	$24K
12002		<1%	150	$24K
82962		<1%	24,717	$23K
86803		<1%	4,085	$23K
99152		<1%	2,916	$22K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	12,251	$22K
87088		<1%	8,332	$22K
87081		<1%	5,129	$22K
87486		<1%	1,041	$22K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,142	$22K
83516		<1%	2,318	$21K
97802		<1%	340	$21K
82746		<1%	3,458	$21K
87511		<1%	1,569	$20K
86850		<1%	5,743	$19K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	15,898	$19K
87340		<1%	4,853	$19K
86900		<1%	6,225	$19K
90472	Immunization administration, each additional vaccine (list separately)	<1%	1,898	$19K
72050		<1%	870	$19K
11901		<1%	165	$18K
0001A		<1%	470	$18K
78815	Positron emission tomography (PET) for limited area imaging	<1%	41	$18K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	12,781	$17K
82784		<1%	2,068	$17K
73564		<1%	592	$17K
81002		<1%	30,523	$17K
J7050	Infusion, normal saline solution, 250 cc	<1%	22,626	$16K
87581		<1%	1,041	$16K
A9585	Injection, gadobutrol, 0.1 ml	<1%	3,403	$16K
84403		<1%	1,440	$16K
82043		<1%	4,565	$16K
77336		<1%	294	$15K
87481		<1%	2,513	$15K
80074		<1%	1,070	$15K
51798		<1%	3,267	$14K
93296		<1%	1,503	$14K
87205		<1%	7,783	$14K
20553		<1%	131	$14K
94726		<1%	530	$14K
86787		<1%	2,743	$13K
73100		<1%	468	$13K
90750		<1%	177	$13K
76937		<1%	666	$13K
82105		<1%	1,220	$13K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	13,798	$13K
43235		<1%	28	$13K
83001		<1%	1,140	$12K
84153		<1%	1,542	$12K
71101		<1%	770	$12K
0002A		<1%	330	$12K
99153	Mod sedat endo service >5yrs	<1%	1,567	$12K
94729		<1%	553	$12K
76819	Fetal biophysical profile; without non-stress testing	<1%	223	$12K
85651		<1%	5,284	$12K
86255		<1%	710	$12K
96417		<1%	1,170	$12K
82247		<1%	2,430	$11K
93970		<1%	127	$11K
88142		<1%	744	$11K
J1170	Injection, hydromorphone, up to 4 mg	<1%	11,536	$11K
J0897	Injection, denosumab, 1 mg	<1%	67	$11K
82805		<1%	1,842	$11K
86038		<1%	2,522	$10K
73501		<1%	576	$10K
11045		<1%	39	$10K
73000		<1%	421	$10K
C1769	Guide wire	<1%	1,546	$10K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	3,048	$10K
82550		<1%	3,421	$10K
76820		<1%	253	$10K
69209		<1%	416	$10K
83050		<1%	1,761	$10K
86901		<1%	6,354	$10K
83520		<1%	835	$10K
58300		<1%	84	$10K
84146		<1%	821	$10K
0124A		<1%	375	$9K
85014		<1%	2,714	$9K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	21,356	$9K
72072		<1%	476	$9K
87522	Neg quan hep c or qual rna	<1%	339	$9K
86762		<1%	2,528	$8K
73120		<1%	327	$8K
90734		<1%	1,305	$8K
82248		<1%	2,515	$8K
88307		<1%	152	$8K
64721		<1%	13	$8K
80076		<1%	1,412	$8K
86704		<1%	1,708	$8K
85007		<1%	3,359	$8K
88342		<1%	749	$8K
0072A		<1%	203	$7K
72197		<1%	26	$7K
72070		<1%	430	$7K
82950		<1%	1,860	$7K
87075		<1%	1,834	$7K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	15,879	$7K
86706		<1%	1,691	$7K
83002		<1%	803	$7K
81000		<1%	8,146	$7K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	6,040	$7K
86695		<1%	939	$7K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	67	$7K
76942		<1%	110	$7K
0064A		<1%	228	$7K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	761	$7K
36000		<1%	2,080	$7K
0054A		<1%	249	$7K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	8,220	$7K
84460		<1%	2,905	$7K
85652		<1%	4,596	$7K
85018		<1%	4,081	$7K
88304		<1%	1,278	$6K
11730		<1%	44	$6K
0004A		<1%	224	$6K
20605		<1%	44	$6K
87428		<1%	6,050	$6K
76882		<1%	68	$6K
84550		<1%	2,774	$6K
87529		<1%	247	$6K
73660		<1%	402	$6K
87521	Neg quan hep c or qual rna	<1%	209	$6K
98925		<1%	478	$6K
84156		<1%	2,181	$5K
86696		<1%	1,089	$5K
90707		<1%	1,342	$5K
87210		<1%	1,880	$5K
84481		<1%	635	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	501	$5K
92557		<1%	255	$5K
82375		<1%	1,775	$5K
84703		<1%	1,687	$5K
77002		<1%	59	$5K
83615		<1%	2,371	$5K
84450		<1%	2,240	$5K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	795	$5K
86200		<1%	1,275	$5K
99213	Doctor's office visit, returning patient (routine)	<1%	123	$5K
81003		<1%	4,503	$5K
74022		<1%	231	$5K
51702		<1%	511	$5K
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,202	$5K
20600		<1%	40	$5K
86694		<1%	317	$5K
29105		<1%	43	$5K
83883		<1%	476	$5K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	5,024	$5K
87653		<1%	291	$5K
92652		<1%	78	$4K
80069		<1%	976	$4K
93308		<1%	26	$4K
84402		<1%	416	$4K
93299		<1%	333	$4K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	15,287	$4K
82947		<1%	1,211	$4K
90732		<1%	387	$4K
85732		<1%	2,460	$4K
72156		<1%	13	$4K
90648		<1%	2,362	$4K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	970	$4K
17004		<1%	163	$4K
64405		<1%	323	$4K
82565		<1%	1,612	$4K
94761		<1%	1,879	$4K
96368		<1%	524	$4K
J3490	Unclassified drugs	<1%	4,610	$4K
92567		<1%	432	$4K
73522		<1%	189	$4K
72202		<1%	246	$4K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,463	$4K
84100		<1%	2,246	$4K
J2060	Injection, lorazepam, 2 mg	<1%	3,603	$4K
80175		<1%	236	$4K
J1756	Injection, iron sucrose, 1 mg	<1%	752	$4K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	15	$4K
95819		<1%	25	$4K
91322		<1%	501	$4K
71271		<1%	39	$3K
90480		<1%	668	$3K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,742	$3K
78264		<1%	14	$3K
97166		<1%	94	$3K
31575		<1%	45	$3K
11720		<1%	77	$3K
95909		<1%	83	$3K
29130		<1%	12	$3K
0052A		<1%	86	$3K
C1776	Joint device (implantable)	<1%	26	$3K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	1,470	$3K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	2,022	$3K
98929		<1%	128	$3K
94799		<1%	644	$3K
73620		<1%	147	$3K
92610		<1%	103	$3K
74183		<1%	14	$3K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	3,518	$3K
94664		<1%	330	$3K
90620		<1%	1,227	$3K
80143		<1%	765	$3K
86431		<1%	853	$3K
82274		<1%	373	$3K
84165		<1%	764	$2K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	5,711	$2K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,276	$2K
86160		<1%	533	$2K
0051A		<1%	73	$2K
82670		<1%	283	$2K
87147		<1%	926	$2K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,199	$2K
82077		<1%	2,548	$2K
93798		<1%	55	$2K
77080		<1%	38	$2K
83013		<1%	113	$2K
74420		<1%	13	$2K
J1815	Injection, insulin, per 5 units	<1%	5,835	$2K
95911		<1%	12	$2K
72170		<1%	167	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	22,528	$2K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	213	$2K
80177		<1%	138	$2K
82553		<1%	214	$2K
87808		<1%	1,349	$2K
92526		<1%	52	$2K
86376		<1%	210	$2K
82652		<1%	223	$2K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	585	$2K
84436		<1%	287	$2K
97165		<1%	41	$2K
74019		<1%	97	$2K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,928	$2K
86430		<1%	545	$1K
J2785	Injection, regadenoson, 0.1 mg	<1%	367	$1K
80179		<1%	705	$1K
90746		<1%	97	$1K
92551		<1%	70	$1K
72114		<1%	38	$1K
86162		<1%	426	$1K
82977		<1%	365	$1K
76000		<1%	78	$1K
94644		<1%	102	$1K
C1889	Implantable/insertable device, not otherwise classified	<1%	27	$1K
73700		<1%	29	$1K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,476	$1K
0074A		<1%	27	$1K
36430		<1%	19	$1K
83721		<1%	597	$1K
82140		<1%	194	$1K
86317		<1%	215	$1K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	377	$1K
C1758	Catheter, ureteral	<1%	1,393	$1K
36416		<1%	982	$1K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	472	$1K
72082		<1%	40	$1K
G0008	Administration of influenza virus vaccine	<1%	1,504	$1K
82150		<1%	220	$1K
72120		<1%	54	$1K
72146		<1%	13	$1K
84520		<1%	680	$1K
0081A		<1%	25	$1K
84479		<1%	250	$1K
84112		<1%	199	$969.29
90688		<1%	249	$955.43
82677		<1%	46	$947.71
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	16	$936.00
73552		<1%	57	$930.91
72131		<1%	13	$914.41
87186		<1%	334	$912.86
97535	Self-care/home management training, each 15 minutes	<1%	67	$887.62
86364		<1%	402	$877.20
82378		<1%	154	$874.65
90678		<1%	125	$870.86
86308		<1%	242	$832.65
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	7,358	$831.85
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,937	$825.86
82533		<1%	77	$814.34
84478		<1%	518	$804.56
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,544	$769.91
74174		<1%	16	$762.26
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	247	$730.00
86300		<1%	73	$719.33
90656		<1%	131	$703.90
96402		<1%	73	$694.35
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,852	$680.88
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	5,824	$633.16
86708		<1%	125	$619.78
73060		<1%	51	$604.25
87641		<1%	65	$590.23
82040		<1%	214	$588.45
91321		<1%	32	$570.77
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	2,936	$552.40
0003A		<1%	13	$527.50
87807		<1%	477	$526.06
84155		<1%	466	$525.13
Q2034	Influenza virus vaccine, split virus, for intramuscular use (agriflu)	<1%	387	$510.56
80164		<1%	42	$498.97
0082A		<1%	12	$496.48
0352U		<1%	1,340	$488.08
88360		<1%	13	$463.73
95874		<1%	274	$460.61
93289		<1%	51	$459.87
93288		<1%	63	$409.77
17003		<1%	249	$408.78
84075		<1%	162	$390.64
85045		<1%	182	$375.78
J1790	Injection, droperidol, up to 5 mg	<1%	735	$373.49
90662		<1%	477	$358.07
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	28	$355.86
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	279	$354.62
86800		<1%	99	$350.52
88312		<1%	87	$342.99
80178		<1%	37	$321.30
86231		<1%	119	$318.77
86580		<1%	52	$318.70
86003		<1%	45	$315.95
81374		<1%	108	$311.06
J2550	Injection, promethazine hcl, up to 50 mg	<1%	1,377	$309.38
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	<1%	40	$306.95
97116		<1%	43	$300.16
83010		<1%	36	$283.87
88341		<1%	58	$280.27
86780		<1%	25	$278.03
J3480	Injection, potassium chloride, per 2 meq	<1%	504	$275.06
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,136	$273.69
94760		<1%	133	$268.05
82310		<1%	148	$262.45
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	6,254	$261.44
86336		<1%	46	$259.83
J1650	Injection, enoxaparin sodium, 10 mg	<1%	171	$236.26
85049		<1%	148	$235.22
90716		<1%	1,299	$233.86
82009		<1%	25	$232.91
95024		<1%	12	$222.57
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,016	$220.60
72220		<1%	13	$208.04
86705		<1%	40	$206.89
90710		<1%	1,346	$201.92
87338		<1%	24	$199.88
82172		<1%	36	$196.22
A6449	Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard	<1%	2,591	$193.40
99497		<1%	14	$192.26
90680		<1%	2,782	$177.47
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	40	$172.27
86735		<1%	24	$171.20
90792	Psychiatric diagnostic evaluation with medical services	<1%	13	$157.24
87184		<1%	66	$155.75
0296T		<1%	13	$142.69
90698		<1%	2,281	$137.14
86778		<1%	13	$135.33
99495		<1%	25	$135.23
J3372	Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg	<1%	134	$132.58
86225		<1%	60	$126.46
87045		<1%	14	$123.81
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	12	$123.65
36600		<1%	30	$123.20
83718		<1%	18	$122.80
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	166	$115.90
J1171	Injection, hydromorphone, 0.1 mg	<1%	211	$114.30
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	74	$113.32
86765		<1%	23	$109.97
87563		<1%	26	$109.23
J7070	Infusion, d5w, 1000 cc	<1%	67	$107.46
83020		<1%	14	$106.40
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	44	$105.31
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	12	$105.26
0353U		<1%	1,435	$103.19
85613		<1%	17	$101.97
82951		<1%	12	$99.33
J0780	Injection, prochlorperazine, up to 10 mg	<1%	57	$98.53
G0433	Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening	<1%	268	$94.70
84132		<1%	63	$93.49
J3360	Injection, diazepam, up to 5 mg	<1%	34	$92.70
87427		<1%	14	$91.14
J1630	Injection, haloperidol, up to 5 mg	<1%	804	$88.94
J8540	Dexamethasone, oral, 0.25 mg	<1%	3,432	$88.74
A6454	Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard	<1%	1,511	$86.21
91305		<1%	504	$79.94
J1956	Injection, levofloxacin, 250 mg	<1%	54	$75.52
83525		<1%	12	$72.75
86258		<1%	30	$69.99
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,321	$69.39
82465		<1%	18	$66.69
90633		<1%	2,751	$64.70
87046		<1%	14	$62.11
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	103	$61.42
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	214	$59.89
J1940	Injection, furosemide, up to 20 mg	<1%	106	$57.09
90696		<1%	1,218	$55.92
86334		<1%	12	$54.60
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	23	$54.45
82390		<1%	12	$52.41
93297		<1%	12	$51.96
96127		<1%	13	$49.79
82952		<1%	12	$49.63
90619		<1%	1,062	$48.59
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	1,650	$45.70
84295		<1%	27	$43.76
82374		<1%	27	$43.76
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	660	$43.25
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,297	$36.08
90723		<1%	876	$35.80
88720		<1%	33	$35.06
90700		<1%	1,193	$34.58
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	157	$29.80
90744		<1%	1,369	$28.90
90681		<1%	368	$23.78
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	32	$22.98
J3411	Injection, thiamine hcl, 100 mg	<1%	55	$19.35
87101		<1%	13	$17.30
J1836	Injection, metronidazole, 10 mg	<1%	21	$13.24
99406		<1%	493	$12.41
81015		<1%	331	$12.14
Q4012	Cast supplies, short arm cast, pediatric (0-10 years), fiberglass	<1%	14	$10.68
A9270	Non-covered item or service	<1%	7,878	$10.62
A4615	Cannula, nasal	<1%	305	$9.11
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	215	$8.40
G0009	Administration of pneumococcal vaccine	<1%	154	$7.61
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	1,478	$5.12
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	30	$3.18
A4300	Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access	<1%	17	$1.33
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	17	$0.03
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	3,781	$0.01
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	0%	155	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	216	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	157	$0.00
G8990	Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals	0%	166	$0.00
91308		0%	44	$0.00
91311		0%	14	$0.00
91300		0%	1,091	$0.00
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	0%	12	$0.00
91312		0%	423	$0.00
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	12	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	12	$0.00
85060		0%	13	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	17	$0.00
90697		0%	24	$0.00
91307		0%	923	$0.00
90381		0%	39	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	470	$0.00
G8991	Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	190	$0.00
91301		0%	32	$0.00
91306		0%	226	$0.00
P9612	Catheterization for collection of specimen, single patient, all places of service	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCESENA, TAMARA (CFO)

Same official

Other billing entities under CESENA, TAMARA

Full network →

Provider	Location	Paid
Public Hospital Dist No 1 Skagit	Mount Vernon, WA	$24.73M
Public Hospital Dist No 1 Skagit	Darrington, WA	$1.06M
Public Hospital District No 1 Skagit	Arlington, WA	$974K
Public Hospital Dist No 1 Skagit	Granite Falls, WA	$263K
Public Hospital Dist No 1 Skagit	Arlington, WA	$13K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.